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Aminooxy glycosideThe stability of the amino(methoxy) beta-glycosidic bond to glycosidase catalysed hydrolysis is reported.
Beta-O-benzyl glucose and beta-O-benzyl galactose are substrates hydrolysed by beta-glucosidase and
beta-galactosidase from almonds and Escherichia coli, respectively. However their beta-N-benzyl-(O-
methoxy)-glucoside and beta-N-benzyl-(O-methoxy)-galactoside derivatives are competitive inhibitors.
 2013 Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/3.0/).In recent years, the chemoselective ligation of secondary meth-
oxyamine derivatives (sugars, peptides, sterols) with unprotected
and non-activated reducing sugars has emerged as an efﬁcient
route to access a variety of N-(O-methoxy)-linked neoglycoconju-
gates in a manner, which bypasses the need for extensive protect-
ing group manipulation of the donor sugars (Scheme 1).1 These
ligation methods proceed under mildly acidic conditions where
the aminoxy group 2 selectively reacts with the aldehyde of the
reducing sugar (in its ring opened form) 1a to give an oxy-immin-
ium intermediate 3 (Scheme 1). Subsequent ring closure results in
the predominant formation of the b-linked N-(O-methoxy)-glyco-
side 3a in the pyranose form. There are only a few exceptions to
this b-selectivity such as mannose, which favours the a-conﬁgured
product. Some reactions using galactose and mannose have also
been reported where the furanose ligation adducts are observed
as minor products.1,2
To date, these methods have been employed to prepare a vari-
ety of neoglycoconjugates,1,3–6 glycopeptides1,7 and glycoproteins.8
These procedures have also been adapted for the facile neoglyco-
randomisation of secondary alkoxyamine derivatives of the agly-
con portion of glycosylated natural products such as digitoxin,9,10
colchicine11 and vancomycin.12 Fluorous-tagged2 and alkylamine
functionalised methoxyamine ligands13 have been exploited for
the incorporation of reducing sugars onto microarrays. Considering
their ease of preparation and the potential uses across a broad
spectrum of biological applications we were interested in compar-
ing the relative stability of O-linked and O-methoxy-N-linked gly-
cosides to glycosidase catalysed hydrolysis. The inhibition ofbovine liver b-galactosidase by 1 mM concentrations of b-1,4-
N(OMe)-linked disaccharides have previously been reported.5
However, in these assays, enzyme activity was monitored by the
release of the para-nitrophenol chromophore from pNP-b-Gal, so
any hydrolysis of the N(OMe)-glycosidic bond of the inhibitor(s)
would not have been detected under these conditions. Herein,
we report the stability studies of two N(OMe)-glycosides, 7 and 8
(Scheme 2), towards enzyme catalysed hydrolysis by retaining
b-glycosidases.
Benzyl b-D-glucopyranoside 514 and benzyl b-D-galactopyrano-
side 615 were prepared as previously described. Aminooxy
glycosides 7 and 8 were prepared by stirring a twofold excess of
D-glucose or D-galactose with N-benzyl-O-methyl-hydroxylamine
416 in a 3:1 DMF/AcOH solvent mixture at 40 C for 6 days and
were isolated in 45% and 63% yields, respectively. Proton NMR
analysis of the crude product mixture showed exclusive formation
of the beta-anomeric products.
Before studying the enzymatic stability of aminooxy glycosides 7
and 8, it was important to ﬁrst establish that their O-glycoside
analogues 5 and 6were themselves susceptible to enzymatic hydro-
lysis using the glycosidases chosen for this study. The Km value for
benzyl-b-D-glucoside 5was determined using a continuous coupled
assay (Scheme 3) where almond b-glycosidase (GlcH) activity was
measured by the increase in absorbance at 340 nm due to the
NADP+-dependent oxidation of the liberated D-glucose to D-glucon-
olactone by Thermoplasma acidophilum glucose dehydrogenase
(GDH). GDH also oxidises D-galactose with comparable efﬁciency,17
so the same assay procedures were used to determine substrate
kinetics for benzyl-b-D-galactoside 6with Escherichia coli b-galacto-
sidase (GalH). Both 5 and 6 proved to be substrates for their
respective b-glycosidases with low millimolar Km values (Table 1).
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Scheme 1. Mechanism for aminooxy glycoside formation via reaction between
reducing sugars and O,N-disubstituted hydroxylamines.
Table 1
Substrate and inhibitor properties of 5–8 with GlcH and GalH
Compound Enzyme Km (mM) Ki (mM) Vmax (lmol min1 mg1)
5 GlcH 4.77 (±0.53) — 0.17 (±0.01)
7e GlcH —a 3.00 (±0.57)c —a
6 GalH 1.37 (±0.08) — 0.74 (±0.02)
8e GalH —b 2.60 (±0.29)d —b
a No hydrolysis of 7 (4 mM) by GlcH (0.23 units mL1).
b No hydrolysis of 8 (4 mM) by GalH (11.5 units mL1).
c Competitive inhibition w.r.t. 5.
d Competitive inhibition w.r.t. 6.
e GalH is not inhibited by compound 7 and GalH is not inhibited by compound 8.
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Scheme 3. Coupled assay for substrate/inhibitor analyses of 5–8.
2 A. Iqbal et al. / Carbohydrate Research 377 (2013) 1–3Initial incubations of N(OMe)-galactoside 8 (600 lM) with GalH
under the coupled assay procedures described above (Scheme 3)
exhibited slow NADP+ consumption suggesting enzymatic libera-
tion of galactose from 8. However, the same rate of NADP+
consumption was also observed when the experiment was
repeated in the absence of GalH suggesting either the presence of
galactose contamination in the assay mixture or that GDH was able
to oxidise 8 in an NADP+-dependent manner. The latter was ruled
out because the increase in absorbance at 340 nm reached a
plateau long before NADPH levels were depleted. Based on the
net increase in absorbance at 340 nm the assay concentration of
galactose was determined as 24 lM by enzymatic titration. These
initial experiments were performed using a stock solution of 8
(pH 6.2), which had been prepared and stored at room temperature
for 20 days. When the assay was repeated using a freshly prepared
stock solution of 8 no NADP+ consumption was observed indicating
that 8 was subject to slow chemical hydrolysis upon storage in
mildly acidic solution. For subsequent enzymatic stability assays,
to ensure that any absorbance increase at 340 nm could not beattributed to enzymatic hydrolysis of the N(OMe) linkage, solu-
tions of 7 and 8 were freshly made on the day of use and were ﬁrst
pre-incubated with GDH and NADP+ (30 min) prior to the subse-
quent addition of the glycosidase enzyme. Under these conditions
neither 7 nor 8 showed any evidence of enzymatic hydrolysis
Table 1. Further analysis of 7 and 8 showed them to be competitive
inhibitors of GalH and GlcH, respectively, with Ki values similar to
the Km values observed for their respective competing substrates, 5
and 6 (Table 1). This demonstrates that the N(OMe) group could
serve as a useful bioisostere for the exo-cyclic anomeric oxygen
in the design of glycosidase resistant glycoside analogues. It is
noteworthy that previous studies of hydrolytic stability of amino-
oxy glycoconjugates under acidic conditions have demonstrated
how they become increasingly stable as the pH approaches
neutrality.18 Collectively, these results suggest that degradation
of aminooxy glycoconjugates in vivo is more likely to arise from
acid-catalysed, rather than glycosidase-catalysed hydrolysis.
1. Experimental
1.1. General
Chemical reagents and enzymes were purchased from Sigma–
Aldrich. Sonication-mediated reactions were carried out using a
Branson model 2510 sonicator bath operating at a frequency of
40 kHz. 1H and 13C NMR spectra were measured on Varian Unity
Plus 400 NMR spectrometer and were referenced to the deuterated
NMR solvent. Optical rotations ([a]D) were obtained with a Perkin-
Elmer Model 241 Polarimeter, using the speciﬁed solvent and
concentration, and are quoted in units of 101 deg cm2 g1. High-
resolution electrospray mass spectra were conducted at the EPSRC
National Mass Spectrometry Service Centre at Swansea University
using a Finnigan MAT 900 XLT with polyethyleneimine as the
reference compound. T. acidophilum glucose dehydrogenase
(GDH), E. coli b-galactosidase (GalH) and almond b-glucosidase
(GlcH) were purchased from Sigma. One unit of GalH activity is
deﬁned as the amount of GalH required to hydrolyse 1 lmol of
O-nitrophenyl-b-D-galactoside per minute under saturating
substrate conditions at 37 C and pH 7.3. One unit of GlcH activity
is deﬁned as the amount of GlcH required to liberate 1 lmol of
glucose from salicin per minute under saturating substrate
conditions at 37 C and pH 5.0.
1.2. Benzyl methoxyamine b-D-glucopyranoside (7)
A solution of D-glucose (360 mg, 2 mmol) and N-benzyl-
O-methyl hydroxylamine 4 (137 mg, 1 mmol) dissolved in a 3:1
solvent mixture of DMF/AcOH (16 mL) was stirred at 40 C for
6 days. The reaction mixture was then concentrated on a rotary
evaporator and puriﬁed by chromatography eluting with a
stepwise solvent gradient of CH2Cl2/MeOH (9:1 to 8:2) to give 7
(135 mg, 45%) as a white solid. ½a22D 6.1 (c 1.0, MeOH);
A. Iqbal et al. / Carbohydrate Research 377 (2013) 1–3 3dH (400 MHz; CD3OD) 3.02–3.10 (1H, m, H-5), 3.18–3.26 (2H, m,
H-4, H-3), 3.43 (1H, t, J 9.0, H-2), 3.61 (1H, dd, J 12.1, 5.6, H-6a),
3.80 (3H, dd, J 12.1, 2.2, H-6b), 3.83 (1H, d, J 9.0, H-1), 3.97 (1H,
d, J 12.6, Ph-CHaHb), 4.10 (1H, d, J 12.6, Ph-CHaHb), 7.13–7.24
(3H, m, 3  Ar-H), 7.30–7.38 (2H, m, 2  Ar-H); dC (100 MHz;
CD3OD) 57.77 (CH2-Ph), 62.69 (OMe), 63.02 (CH2OH), 71.40 (C-3),
71.69 (C-2), 79.68 (C-4), 79.88 (C-5), 93.38 (C-1), 128.61, 129.40,
131.36, 138.64 (Ph); m/z (ES+) 317.1707 (M+NH4+, C14H25N2O6)
requires 317.1703.
1.3. Benzyl methoxyamine b-galactopyranoside (8)
Compound 8 was synthesised from D-galactose as described for
compound 7 and was obtained in 63% isolated yields as a white
solid. ½a22D 10.3 (c 1.0, MeOH); dH (400 MHz; CD3OD) 3.17–3.26
(2H, m, H-3, H-5), 3.64 (1H, dd, J 11.5. 5.2, H-6a), 3.70–3.76 (3H,
m, H-6b, H-2, H-4), 3.84 (1H, d, J 9.0, H-1), 3.96 (1H, d, J 12.8,
Ph-CHaHb), 4.09 (1H, d, J 12.8, Ph-CHaHb), 7.13–7.24 (3H, m,
3  Ar-H), 7.30–7.38 (2H, m, 2  Ar-H); dC (100 MHz; CD3OD)
57.35 (CH2-Ph), 62.47 (OMe), 62.85 (CH2OH), 78.68 (C-5), 76.58
(C-3), 70.75, 69.19 (C-2, C-4), 94.12 (C-1), 138.94, 131.21, 129.34,
128.49 (Ph); m/z (ES+) 317.1707 (M+NH4+, C14H25N2O6) requires
317.1711.
1.4. Enzyme assays
Enzyme substrate assays were carried out in a ﬁnal volume of
200 lL in a 96-well microplate at 37 C containing GlcH (50 mU)
or GalH (2.3 U), PIPES (10 mM), NaOAc (20 mM), EDTA (0.1 mM),
NADP+ (0.6 mM), GlcDH (0.9 U) at pH 6.2 and varying concentra-
tions of substrates. Substrate stock solutions were made up using
co-solvent mixtures of assay buffer and DMSO; ﬁnal assay
mixtures contained 4% DMSO. Enzyme activity was monitored by
the increase in absorbance at 340 nm due to NADPH formation
using a Polarstar Optima microplate reader. Initial rates were
measured from the linear region of product formation For Ki
determinations, inhibition assays were carried out at three or more
different inhibitor concentrations and six substrate concentrations.Initial rates (v) were measured from the linear region of product
formation. Kinetic data were analysed and Km, Vmax and Ki values
determined (by non-linear regression with the appropriate rate
equations) using Graﬁt Version 5 (Erithacus Software Ltd).
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